Ube, Japan

Teruhiko Inoue

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 243(Granted Patents)


Location History:

  • Ube, JA (1977)
  • Osaka, JP (2007)
  • Ube, JP (1985 - 2013)
  • Takatsuki, JP (2007 - 2021)

Company Filing History:


Years Active: 1977-2021

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Teruhiko Inoue: Innovator in Pharmaceutical Chemistry

Introduction

Teruhiko Inoue is a prominent inventor based in Ube, Japan, known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 20 patents, he has made strides in developing innovative methods for producing compounds that have therapeutic applications.

Latest Patents

One of his latest patents is a method for producing an indole compound, which aims to provide a new approach for creating a compound with ITK inhibitory action. This compound is useful for the prophylaxis or treatment of inflammatory diseases. Another notable patent is a method of treatment involving the coadministration of aspirin and prasugrel, designed to prevent diseases caused by thrombus or embolus. This method involves the separate administration of specific compounds in pharmacologically effective amounts to warm-blooded animals.

Career Highlights

Throughout his career, Teruhiko Inoue has worked with notable companies such as Ube Industries, Inc. and Sankyo Company, Limited. His work in these organizations has contributed to advancements in drug development and therapeutic methods.

Collaborations

He has collaborated with esteemed colleagues, including Fumitoshi Asai and Atsuhiro Sugidachi, to further enhance his research and innovation in the field.

Conclusion

Teruhiko Inoue's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…